Standard Biotools (LAB) EBT Margin (2010 - 2026)
Standard Biotools (LAB) posted quarterly EBT Margin of 69.11% for Q1 2026, up 4704.0% year-over-year from 1.44% in Q1 2025, and down 367.89% quarter-over-quarter from 25.8% in Q4 2025.
Standard Biotools (LAB) EBT Margin (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has reported EBT Margin for 17 consecutive years, with 69.11% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT Margin rose 4704.0% year-over-year to 69.11%; the TTM figure through Mar 2026 stood at 69.16% (down 3406.0% YoY), while the FY2025 annual figure was 80.31%, down 5367.0% from the prior year.
- EBT Margin retreated to 69.11% in Q1 2026 per LAB's latest filing, from 25.8% in the prior quarter.
- Across five years, EBT Margin topped out at 567.21% in Q4 2022 and bottomed at 346.98% in Q2 2022.
- Historically, EBT Margin has averaged 51.95% across 5 years, with a median of 82.58% in 2023.
- On a YoY basis, EBT Margin climbed as much as 28647 bps in 2023 and fell as far as 51868 bps in 2023.
- Standard Biotools' EBT Margin stood at 567.21% in 2022, then slumped by 91 bps to 48.53% in 2023, then jumped by 226 bps to 158.4% in 2024, then tumbled by 84 bps to 25.8% in 2025, then sank by 368 bps to 69.11% in 2026.
- Business Quant data shows LAB's EBT Margin at 69.11% in Q1 2026, 25.8% in Q4 2025, and 168.27% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.34 Bn | 7.27 Bn | 12.10% |
| 2 | Stryker | 127.40 Bn | 123.93 Bn | 4.50 Bn | 23.74% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 73.24 Bn | 72.71 Bn | 3.85 Bn | 19.48% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.70 Bn | 1.35 Bn | 29.86% |
| 6 | Dexcom | 34.39 Bn | 32.44 Bn | 830.00 Mn | 24.27% |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | 13.09% |
| 8 | Koninklijke Philips | 26.34 Bn | 23.02 Bn | 4.55 Bn | 8.91% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 18.32% |
| 10 | Standard Biotools | 253.41 Mn | -223.31 Mn | 10.54 Mn | -106.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -106.62% |
| Mar 31, 2026 | -69.11% |
| Dec 31, 2025 | 25.80% |
| Sep 30, 2025 | -168.27% |
| Jun 30, 2025 | -84.01% |
| Mar 31, 2025 | -116.16% |
| Dec 31, 2024 | 158.40% |
| Sep 30, 2024 | -98.71% |
| Jun 30, 2024 | -112.95% |
| Mar 31, 2024 | -70.33% |
| Dec 31, 2023 | 48.53% |
| Sep 30, 2023 | -82.58% |
| Jun 30, 2023 | -60.50% |
| Mar 31, 2023 | -66.01% |
| Dec 31, 2022 | 567.21% |
| Sep 30, 2022 | -117.52% |
| Jun 30, 2022 | -346.98% |
| Mar 31, 2022 | -290.00% |
| Sep 30, 2021 | -57.86% |
| Jun 30, 2021 | -59.79% |